Navigation Links
FDA Approves Lamictal®XR™ (Lamotrigine) for Conversion to Monotherapy for Treatment of Partial Seizures in Appropriate Patients
Date:4/25/2011

ivity to light, muscle pains, chills, confusion, or drowsiness.

Meningitis has many causes other than Lamictal XR, which a doctor would check for if a patient developed meningitis while taking Lamictal XR.

Patients should not stop taking Lamictal XR without talking to their healthcare provider. Stopping Lamictal XR suddenly may cause serious problems.

Patients should always check that they receive LamictalXR.Patients prescribed Lamictal have sometimes been given the wrong medicine because many medicines have names similar to Lamictal, so patients should always check that they receive LamictalXR. Taking the wrong medication can cause serious health problems. When a healthcare provider gives a patient a prescription for Lamictal XR, the patient should:

  • Make sure they can read it clearly.
  • Talk to their pharmacist to check that they are given the correct medicine.
  • Each time they fill their prescription, check the tablets they receive against the pictures of the tablets in the Medication Guide that comes with the prescription.

  • Patients should not take Lamictal XR if they have had an allergic reaction to lamotrigine or to any of the inactive ingredients in Lamictal XR.

    Common side effects include dizziness, tremor, double vision, nausea, vomiting, trouble with balance and coordination, and anxiety. Other common side effects that have been reported with another form of Lamictal include headache, sleepiness, blurred vision, runny nose, and rash. Patients should tell their healthcare provider about any side effect that bothers them or does not go away. Also, patients should tell their healthcare provider if they have any changes in me
    '/>"/>

    SOURCE GlaxoSmithKline
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5

    Related medicine technology :

    1. FDA Approves the First Vaccine to Prevent Meningococcal Disease in Infants and Toddlers
    2. FDA Approves Actemra to Treat Rare Form of Juvenile Arthritis
    3. FDA Approves New Medical Device for Form of Brain Cancer
    4. FDA Approves the NovoTTF-100A System for the Treatment of Patients With Recurrent Glioblastoma Multiforme (GBM) Brain Tumors
    5. FDA Approves Horizant To Treat Restless Legs Syndrome
    6. FDA Approves New Treatment for Rare Form of Thyroid Cancer
    7. FDA Approves Special Protocol Assessment for Phase 3 Trial of Polaris Groups Cancer Therapeutic, ADI-PEG 20, in the Treatment of Hepatocellular Carcinoma
    8. FDA Approves Hyperopia Application for the MEL 80 Excimer Laser from Carl Zeiss Meditec
    9. FDA Approves New Treatment for a Type of Late-Stage Skin Cancer
    10. FDA Approves Zostavax Vaccine to Prevent Shingles in Individuals 50 to 59 Years of Age
    11. FDA Approves Gadavist for Central Nervous System Scans
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:1/23/2015)... Jan. 23, 2015  MedScope ( www.medscope.org ), the leading ... a 2015 Connected World magazine Connected World ... (mPERS), that can be used anywhere, anytime. The nomination ... In nominating MedScope, Landon Garner , ...
    (Date:1/23/2015)... baseball,s all-time hits leader, is the new spokesperson for the ... has announced. "Pete,s a Hall of Famer in ... board with Myoflex," said Ducere Pharma Chief Executive Officer ... known across all generations. The passion and intensity that Pete ...
    (Date:1/23/2015)... , Jan. 23, 2015  Lixte Biotechnology Holdings, Inc. (OTCQB: ... Phase I trial of Lixte,s lead compound, LB‑100, is being ... John S. Kovach , M.D., the founder and ... to be completed at a single site. Accrual of patients, ...
    Breaking Medicine Technology:MedScope Nominated by RacoWireless for Prestigious 2015 Connected World Magazine Connected World Award 2Pete Rose bets on Myoflex to relieve aches and pains 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 3
    ... Careers, the leading online career service for postgraduate life ... for life science Master,s and PhD graduates October 5-6. ... with and interview alumni and degree candidates from more ... leaving their office. "We are excited about ...
    ... NATICK, Mass., May 10, 2011 Boston Scientific Corporation ... to the Asthma and Allergy Foundation of America (AAFA) ... of asthma management and treatment.  The Company,s support coincides ... According to AAFA, more than 20 million ...
    Cached Medicine Technology:Online Career Service to Hold World's First Virtual Job Summit for Postgraduate Life Scientists 2Boston Scientific Supports Asthma Awareness Month With Donation to Asthma Foundation 2Boston Scientific Supports Asthma Awareness Month With Donation to Asthma Foundation 3Boston Scientific Supports Asthma Awareness Month With Donation to Asthma Foundation 4
    (Date:1/22/2015)... New York, New York (PRWEB) January 22, 2015 ... ( http://www.vaginalmeshlawsuit2015.com/ ) in the U.S. District Court, Southern District ... against C.R. Bard, Inc. in that proceeding’s first bellwether trial. ... defense request for a new trial after finding that C.R. ...
    (Date:1/22/2015)... (PRWEB) January 22, 2015 Thousand of ... Medical Care recalled its GranuFlo and NaturaLyte dialysis concentrates ... underway in U.S. District Court, District of Massachusetts, Bernstein ... 20th, the Court has remanded a case filed by ...
    (Date:1/22/2015)... released a new blog post presenting the basic features of ... an accidental death and dismemberment rider for a car insurance ... benefits if the insured dies in an accident. Accidental death ... insurance. , AD&D is not expensive and can be ...
    (Date:1/22/2015)... Jolla, Calif. (PRWEB) January 22, 2015 ... Assemblymembers Susan Bonilla (D-Concord) and Kristin Olsen (R-Modesto) ... for their leadership in advancing biotechnology, biomedical science, ... Bonilla and Olsen each received the “2014 Life ...
    (Date:1/22/2015)... Four years since the release of their debut recording ... marriage of Avasa & Matthew Love – the duo are pleased ... release through White Swan Records on February 24, 2015. , THE ... path available to all of us to walk out of the ...
    Breaking Medicine News(10 mins):Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 3Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 4Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 3Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 4Health News:Accidental Death and Dismemberment Insurance Can Be Purchased at Low Prices Online 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 3Health News:THE ROAD by Avasa & Matthew Love -- A New Album 2Health News:THE ROAD by Avasa & Matthew Love -- A New Album 3Health News:THE ROAD by Avasa & Matthew Love -- A New Album 4
    ... likely to face infection, bleeding, study finds , , THURSDAY, ... defibrillators (ICDs) who,ve had multiple, previous pocket procedures have ... according to a study that included the 12 largest ... Krahn, of the London Health Sciences Center in Ontario, ...
    ... to blame, Japanese study finds , , THURSDAY, Dec. 11 (HealthDay ... a new Japanese study finds. , Those living in multigenerational ... times more likely to be diagnosed with serious heart disease ... by researchers at Osaka University reported in the Dec. 11 ...
    ... Playing tennis at the age of 90, living well beyond the age ... Researchers have discovered the secret to the fountain of youth. And now, ... ... RATON, Fla. (Business Wire EON) December 11, 2008 -- Natural Health ...
    ... 11 The Susan G. Komen for the Cure(R),Advocacy Alliance ... the next Secretary of Health and Human Services and director ... Alliance noted that,Daschle has long been a leader on health ... years related to breast cancer. , ...
    ... call for Americans to "Tell Their Stories" , ... Obama has indicated that healthcare reform will be a top ... Obama,s offer to serve as health and human services secretary, ... is asking Americans to help with reform efforts by sharing ...
    ... Philadelphia, 11 December 2008 Heart failure (HF) clinics ... patients with heart failure, yet there have been no ... clinics. To address this gap, the Quality of ... (HFSA) has developed a consensus statement summarizing the rationale, ...
    Cached Medicine News:Health News:Multiple ICD Replacements Can Predict Complications 2Health News:Crowded Households Raise Women's Heart Risk 2Health News:Crowded Households Raise Women's Heart Risk 3Health News: Anti-Aging Miracle Physicians Have Been Waiting for is Finally Here : Free Book Available From Natural Health News Report Reveals the Secret to Staying Young 2Health News:Susan G. Komen for the Cure(R) Advocacy Alliance Applauds Selection of Senator Tom Daschle for HHS Secretary, White House Health Reform Czar 2Health News:Hospice Community Encouraged to Respond to Daschle Request to Participate in Information Gathering about Healthcare Concerns 2Health News:New statement outlines essentials of heart failure clinics 2
    The Optima III line of laparoscopic hand instruments provides a well-crafted set of instruments designed for strength and durability....
    The Bair Hugger Model 505 provides safe, quiet and effective warming to patients around the world....
    Bair Hugger temperature management units are the only forced-air warming systems that can be used with an integrated, cost-effective method of fluid warming...
    Provides outstanding patient warming and safety throughout the hospital and is nearly half the size and one-third the weight of earlier units....
    Medicine Products: